Customer Center
Login | Register

xTAG® RESPIRATORY VIRAL PANEL

xTAG Respiratory Viral Panel

Gain confidence in your diagnosis with the comprehensive, multiplex xTAG® RVP assay

xTAG® Respiratory Viral Panel

Accurate detection of respiratory viruses and subtypes is critical for patient care management, disease surveillance, and infection control practices. Detect multiple respiratory viruses, the majority of which readily circulate among the most vulnerable populations—children, the elderly, and the immunocompromised—with xTAG® Respiratory Viral Panel (RVP).


Product Details

Product Details

Workflow

Workflow

Posters

Posters

Ordering

Ordering

Resources

Resources

Support

Support

Instruments supporting this assay

Luminex® 100/200™Luminex 200 Instrument   MAGPIX®*MAGPIX Instrument

For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.

*Only xTAG RVP FAST v2 can be used on our MAGPIX system.

Intended Use (US-IVD)**:

RVP: The xTAG® Respiratory Viral Panel (RVP) is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs from individuals suspected of respiratory tract infections. The following virus types and subtypes are identified using RVP: Influenza A, Influenza B, Respiratory Syncytial Virus subtype A, Respiratory Syncytial Virus subtype B, Parainfluenza 1, Parainfluenza 2, and Parainfluenza 3 virus, Human Metapneumovirus, Rhinovirus, and Adenovirus. The detection and identification of specific viral nucleic acids from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection if used in conjunction with other clinical and laboratory findings. Positive results do not rule out bacterial infection, or co-infection with other viruses. The agent detected may not be the definite cause of disease. The use of additional laboratory testing (e.g. bacterial culture, immunofluorescence, radiography) and clinical presentation must be taken into consideration in order to obtain the final diagnosis of respiratory viral infection. Negative results do not preclude respiratory virus infection and should not be used as the sole basis for diagnosis, treatment or other patient management decisions. The RVP assay cannot adequately detect Adenovirus species C, or serotypes 7a and 41. It is recommended that specimens found to be negative for Adenovirus after examination using RVP be confirmed by an alternate method (e.g., FDA cleared molecular test or cell culture). The RVP primers for detection of rhinovirus cross-react with enterovirus. A rhinovirus reactive result should be confirmed by an alternate method (e.g. cell culture). Performance characteristics for Influenza A virus were established when Influenza A HA subtype H3, subtype H1 (prior to the emergence of subtype 2009 H1N1pdm), and when subtype 2009 H1N1pdm were the predominant Influenza A in circulation. When other Influenza A viruses are emerging, performance characteristics may vary.

RVP FAST: The xTAG® Respiratory Viral Panel Fast (RVP FAST) is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs from individuals suspected of respiratory tract infections. The following virus types and subtypes are identified using RVP FAST: Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza B, Respiratory Syncytial Virus, Human Metapneumovirus, Rhinovirus, and Adenovirus. The detection and identification of specific viral nucleic acids from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection if used in conjunction with other clinical and epidemiological information. Negative results do not preclude respiratory viral infection and should not be used as the sole basis for diagnosis, treatment or other management decisions. Positive results do not rule out bacterial infection or co-infection with other organisms. The agent detected may not be the definite cause of disease. The use of additional laboratory testing (e.g. bacterial and viral culture, immunofluorescence, and radiography) and clinical presentation must be taken into consideration in order to obtain the final diagnosis of respiratory infection.



Intended Use (CA-IVD)**:

RVP: The xTAG® Respiratory Viral Panel Fast (RVP FAST) is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs, nasal aspirates and bronchioalveolar lavages from individuals suspected of respiratory tract infections. The virus types and subtypes detected by RVP FAST are Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza B, Respiratory Syncytial Virus, Coronavirus NL63, Coronavirus OC43, Coronavirus HKU1, Coronavirus 229E, Parainfluenza 1, Parainfluenza 2, Parainfluenza 3, Parainfluenza 4, Human Metapneumovirus, Entero-Rhinovirus, Adenovirus, and Human Bocavirus. The detection and identification of specific viral nucleic acids from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection if used in conjunction with other clinical and laboratory findings.

RVP FAST: The xTAG® Respiratory Viral Panel Fast (RVP FAST) is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs, nasal aspirates and bronchioalveolar lavages from individuals suspected of respiratory tract infections. The virus types and subtypes detected by RVP FAST are Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza B, Respiratory Syncytial Virus, Coronavirus NL63, Coronavirus OC43, Coronavirus HKU1, Coronavirus 229E, Parainfluenza 1, Parainfluenza 2, Parainfluenza 3, Parainfluenza 4, Human Metapneumovirus, Entero-Rhinovirus, Adenovirus, and Human Bocavirus. The detection and identification of specific viral nucleic acids from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection if used in conjunction with other clinical and laboratory findings.

RVP FAST v2: The xTAG® Respiratory Viral Panel Fast v2 (RVP FAST v2) is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs, nasal aspirates and bronchioalveolar lavages from individuals suspected of respiratory tract infections. The virus types and subtypes detected by RVP FAST v2 are Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza A subtype 2009 H1N1, Influenza B, Respiratory Syncytial Virus, Coronavirus NL63, Coronavirus OC43, Coronavirus HKU1, Coronavirus 229E, Parainfluenza 1, Parainfluenza 2, Parainfluenza 3, Parainfluenza 4, Human Metapneumovirus, Enterovirus/Rhinovirus, Adenovirus, and Human Bocavirus. The detection and identification of specific viral nucleic acids from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection when used in conjunction with other clinical and laboratory findings.

**Please contact Luminex at [email protected] to obtain the complete intended uses of these products